Skip to main content
. Author manuscript; available in PMC: 2015 Feb 3.
Published in final edited form as: Cancer Chemother Pharmacol. 2009 Aug 22;65(6):1047–1056. doi: 10.1007/s00280-009-1110-x

Fig. 2.

Fig. 2

Concentration–response curves to doxorubicin or cisplatin. Cells were treated with increasing drug doses for 48 h. a Doxorubicin (nM), b cisplatin (μM). Cytotoxicity was quantified via the MTT assay. Cell survival was standardized to untreated cells (no drug, 100%) under optimal growth conditions. % survival ± SEM was determined from three to five independent experiments, each in triplicates, with p < 0.05 considered significant. Table 1 summarizes IC50